Press Releases

Bora Pharmaceuticals and Celltrion partner to expand OSD capabilities in APAC market

CluePoints Announces Amit Patel as New CFO

CluePoints Announces Amit Patel as New CFO Organizational changes support rapid growth, scale, and focus for RBQM leader

Creative Proteomics Metabolomics Launches Coenzyme A (CoA) Analysis Service for Precision Metabolomics Research

Creative Proteomics Launches BioID Platform for Proximity-Dependent Biotin Identification

Creative Proteomics Lipidomics Aids Environmental Microbial Community Studies with Phospholipid Fatty Acids Analysis Service

Abzena continues to add significant talent to its San Diego Biologics manufacturing facility

Abzena, the leading end-to-end integrated CDMO for complex biologic molecules and Antibody Drug Conjugates (ADCs) has announced the appointment of Sean O’Brien as Senior Vice President and Site Head at its San Diego facility.

TransCure bioServices expands their team to lead the way in animal welfare

TransCure bioServices has announced two new additions to their team, with the aim of further enhancing the care given to their animals while reinforcing their well-established animal welfare policy.

CureSearch to fund Phase I clinical trial for pediatric brain cancer

CureSearch announced a newly-funded Phase I clinical trial led by Dr. David Munn of the Medical College of Georgia at Augusta University. Funded through a CureSearch Catapult Award, Dr. Munn is working to bring new therapies to brain cancer patients.

Simplify Your Microbiome Research with MicrobioSeq’s Microbial Biomarker Discovery Service

CD Genomics Unveils Advanced Mitochondrial Diseases Panel Sequencing Service

CD Genomics Supports Immune and Cancer Research with TCR-Seq Service

MediMergent Leverages Patient-Centric Real-World Data and Evidence Platform to Capture the Voice of the Patient in National Cancer Trial

MediMergent, a leading Real-World Data (RWD) and Evidence (RWE) company, announced the implementation of its digital clinical trials platform for the collection and analysis of RWD in a large multicenter study entitled EIMPRIS (Engaging Immuno-Protection Intervention Study) focused on the prevention of symptomatic SARS-CoV-2 infection in cancer patients.

Progressive Exosome Research Got Full-Fledged Solutions!

A newly released market research reports on the prosperous future of exosome research.

CRO Catawba Research Names Andrew Silverman, Ph.D., as COO

Quotient Sciences Supports Crinetics Pharmaceuticals with Fully Integrated Pediatric Development and Clinical Testing Program

Crinetics Pharmaceuticals, a pharmaceutical company that develops therapies for rare endocrine diseases, and Quotient Sciences, a drug development and manufacturing accelerator, have announced a partnership to support Crinetics’ CRN04894 pediatric program.

Tower Cold Chain secures spot in Financial Times top 1000 fastest-growing companies

Temperature-controlled container specialist, Tower Cold Chain, has secured a position in the Financial Times annual list of Europe’s’ 1000 fastest-growing companies.

CRO Catawba Research Names Andrew Silverman, Ph.D., as COO

Catawba Research, a full-service contract research organization (CRO) for innovative trial management, is delighted to announce Andy Silverman, Ph.D., has joined its leadership team as its chief operating officer (COO).

MedPharm Announces Appointment of New U.S. Director of Analytical

MedPharm, a global CDMO specializing in topical and transdermal development and manufacturing, appoints new U.S. Director of Analytical and announces restructure of analytical suite.

Perovskites Quantum Dots and Display Technology

A Series of Colloidal Materials Newly Launched at Alfa Chemistry: Catalysts, Nanoparticles, and Silica